Analysis of polypeptide expression in benign and malignant human breast lesions: down-regulation of cytokeratins
1996

Polypeptide Expression in Breast Cancer

Sample size: 23 publication Evidence: moderate

Author Information

Author(s): B Franzen, S Linder, AA Alaiya, E Eriksson, K Uruy, T Hirano, K Okuzawa, G Auer

Primary Institution: Karolinska Institute and Hospital

Hypothesis

The study investigates the expression levels of various polypeptides in benign and malignant breast lesions.

Conclusion

The study found that malignant breast carcinomas exhibit decreased levels of cytokeratin polypeptides compared to benign fibroadenomas.

Supporting Evidence

  • PCNA levels were 4.3-fold higher in highly malignant tumours than in non-malignant cells.
  • Cytokeratin levels were significantly lower in carcinomas than in fibroadenomas.
  • Decreases in tropomyosin 2 and 3 were statistically significant in carcinomas.

Takeaway

The study looked at proteins in breast cancer and found that cancer cells have less of certain proteins compared to non-cancer cells.

Methodology

Two-dimensional gel electrophoresis (2-DE) was used to analyze polypeptide expression in breast carcinoma cells and fibroadenoma tissue.

Limitations

The study excluded cases with unclear classification and faced challenges with protein contamination from other cell types.

Participant Demographics

The study included 23 breast lesions, with 6 non-malignant and 17 malignant cases.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication